Loading clinical trials...
Loading clinical trials...
Allogeneic Adipose Tissue Derived Mesenchymal Stromal Cell Therapy for Treating Patients With Severe Respiratory COVID-19. A Danish, Double-blind, Randomized Placebo-controlled Study
Conditions
Interventions
Stem Cell Product
Locations
1
Denmark
2014 Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet
Copenhagen, Denmark
Start Date
April 20, 2020
Primary Completion Date
January 30, 2021
Completion Date
April 30, 2021
Last Updated
May 27, 2020
NCT05907564
NCT04657120
NCT04170348
NCT05622942
NCT05592431
NCT05422326
Lead Sponsor
Rigshospitalet, Denmark
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions